Pal, R., Banerjee, M., Prasad, T. N., Walia, R., Bhadada, T., Singh, J., & Bhadada, S. K. (2024).
Fracture risk and bone health in adrenal adenomas with mild autonomous cortisol secretion/subclinical Hypercortisolism: a systematic review, meta-analysis and meta-regression. Journal of bone and mineral research: the official journal of the American Society for Bone and Mineral Research, zjae067. Advance online publication.
https://doi.org/10.1093/jbmr/zjae067Das, D., Banerjee, M., Kar, A., Bhattacharyya, R., Chowdhury, S., & Mukhopadhyay, S. (2024)
Variable presentation and outcomes of primary hyperparathyroidism in children and adolescents. Journal of pediatric endocrinology & metabolism : JPEM, 10.1515/jpem-2023-0529. Advance online publication.
https://doi.org/10.1515/jpem-2023-0529Banerjee, M., Pal, R., Maisnam, I., & Mukhopadhyay, S. (2024).
GLP-1 receptor agonists, SGLT2 inhibitors and noncardiovascular mortality in type 2 diabetes: Insights from a meta-analysis. Diabetes & metabolic syndrome, 18(1), 102943
https://doi.org/10.1016/j.dsx.2024.102943Banerjee, M., Kar, A., Ahamed, J., Bhattacharjee, R., Maitra, D., Maisnam, I., Das, T. C., Sahana, P. K., Chowdhury, S., & Mukhopadhyay, S. (2023).
Renal Dysfunction in Primary Hyperparathyroidism is associated with nephrolithiasis, elevated serum calcium-phosphate product and parathormone levels. Endocrine, 10.1007/s12020-023-03631-0. Advance online publication.
https://doi.org/10.1007/s12020-023-03631-0Pal R, Banerjee M, Prasad T (2023)
Risk Of Gallstone Disease In Primary Hyperparathyroidism: A Systematic Review And Meta-Analysis. Endocrine Practice.
https://doi.org/10.1016/j.eprac.2023.12.002Banerjee M. (2023).
picardial Fat Paradox and Differential Effects of GLP-1 Receptor Agonists Across Heart Failure Phenotypes. Circulation. Heart failure, e010966. Advance online publication.
https://doi.org/10.1161/CIRCHEARTFAILURE.123.010966Banerjee, M., Maisnam, I., Pal, R., & Mukhopadhyay, S. (2023).
Mineralocorticoid receptor antagonists with sodium-glucose co-transporter-2 inhibitors in heart failure: a meta-analysis. European heart journal, 44(37), 3686–3696
https://doi.org/10.1093/eurheartj/ehad522Dhar A, Banerjee M, Bhattacharjee R, Chowdhury S.
Low DHEAS Level: A Surrogate Marker of Adrenal Cushing Syndrome with Grey Zone ACTH Levels. IJEM. 27(4) 365-367, Jul–Aug 2023. | DOI: 10.4103/ijem.ijem_161_23
Banerjee, M., Mukherjee, A., Hazra, A., & Mukhopadhyay, S. (2023).
Baseline predictors of genital mycotic infections following sodium-glucose cotransporter-2 inhibitors initiation in men with type 2 diabetes. Indian journal of pharmacology, 55(5), 338–339.
Banerjee M, Maisnam I, Mukhopadhyay S. Letter to Editor from Banerjee et al.:
"Glucagon-Like Peptide-1 Receptor Agonists Across the Spectrum of Heart Failure". J Clin Endocrinol Metab. 2023 Aug 25:dgad506.
doi:10.1210/clinem/dgad506.Banerjee M, Mukhopadhyay P, Ghosh S, Basu M, Pandit A, Malik R, Ghosh S.
Corneal Confocal Microscopy Abnormalities in Children and Adolescents With Type 1 Diabetes. Endocr Pract. 2023 Sep;29(9):692-698. doi: 10.1016/j.eprac.2023.06.004.
Banerjee, M.; Mukhopadhyay, P.; Basu, M.; Ghosh, S.
Corneal Confocal Microscopy Identifies Structural Small Fibre Abnormalities in an Adolescent With Type 1 Diabetes and Impaired Awareness of Hypoglycaemia. J ASEAN Fed Endocr Soc 2023.
Banerjee M, Pal R, Mukhopadhyay S, Nair K (2023)
GLP-1 Receptor Agonists and Risk of Adverse Cerebrovascular Outcomes in Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. The Journal of Clinical Endocrinology & Metabolism dgad076.
https://doi.org/10.1210/clinem/dgad076Banerjee M, Mukhopadhyay S. Gout.
New England Journal of Medicine 2023;388:e47.
https://doi.org/10.1056/NEJMc2216467.Banerjee M, Pal R, Maisnam I, Chowdhury S, Mukhopadhyay S
erum uric acid lowering and effects of sodium-glucose cotransporter-2 inhibitors on gout: A meta-analysis and meta-regression of randomized controlled trials. Diabetes Obesity and Metabolism. 2023 Sep;25(9):2697-2703. doi: 10.1111/dom.15157.
Banerjee M, Maisnam I, Mukhopadhyay S (2023)
Impact of Heart Failure History at Baseline on Cardiovascular Effects of GLP-1 Receptor Agonists in Type 2 Diabetes: a Meta-analysis. Cardiovasc Drugs Ther.
https://doi.org/10.1007/s10557-023-07432-5Shetty, A. J., Banerjee, M., Prasad, T. N., Bhadada, S. K., & Pal, R. (2023).
Do vitamin D levels or supplementation play A role in COVID-19 outcomes?-a narrative review. Annals of palliative medicine, apm-23-113. Advance online publication.
https://doi.org/10.21037/apm-23-113Banerjee M, Pal R, Nair K, Mukhopadhyay S (2023)
SGLT2 inhibitors and cardiovascular outcomes in heart failure with mildly reduced and preserved ejection fraction: A systematic review and meta-analysis. Indian Heart Journal S0019483223000433.
https://doi.org/10.1016/j.ihj.2023.03.003Adhikary P, Banerjee M, Banerjee S, et al (2023)
High molecular weight adiponectin and DXA-derived abdominal subcutaneous adipose tissue may independently protect against type 2 diabetes regardless of body mass index. Int J Diabetes Dev Ctries
Banerjee, M., Pal, R., & Mukhopadhyay, S. (2022).
Can SGLT2 inhibitors prevent incident gout? A systematic review and meta-analysis. Acta diabetologica, 59(6), 783–791.
https://doi.org/10.1007/s00592-022-01866-3Basu M, Pulai S, Neogi S, et al (2022)
Prevalence of non-diabetic kidney disease and inability of clinical predictors to differentiate it from diabetic kidney disease: results from a prospectively performed renal biopsy study. BMJ Open Diab Res Care 10:e003058.
https://doi.org/10.1136/bmjdrc-2022-003058Banerjee, M., Pal, R., & Dutta, S. (2022).
Risk of incident diabetes post-COVID-19: A systematic review and meta-analysis. Primary care diabetes, 16(4), 591–593
https://doi.org/10.1016/j.pcd.2022.05.009Banerjee M, Mondal S (2022)
Letter to the Editor from Banerjee and Mondal: “Management of Hyperglycemia in Hospitalized Adult Patients in Non-Critical Care Settings: An Endocrine Society Clinical Practice Guideline.” The Journal of Clinical Endocrinology & Metabolism 107:e4272–e4273
Pal R, Banerjee M, Bhadada SK (2021)
Glycaemic efficacy and safety of mealtime faster‐acting insulin aspart administered by injection as compared to insulin aspart in people with diabetes mellitus: A meta‐analysis of randomized controlled trials. Diabetic Medicine 38:e14515
Pal R, Bhadada S, Mukherjee S, et al (2021)
Fracture risk in hypoparathyroidism: a systematic review and meta-analysis. Osteoporosis International 32:2145–2153
Banerjee M, Basu M, Mukhopadhyay P, Ghosh S (2022)
Nerve conduction study abnormalities in Indian children with type 1 diabetes. Int J Diabetes Dev Ctries
https://doi.org/10.1007/s13410-022-01162-4Pal R, Banerjee M, Bhadada S, et al (2021)
Vitamin D supplementation and clinical outcomes in COVID-19: a systematic review and meta-analysis. Journal of endocrinological investigation 1–16
Basu M, Islam SR, Neogi S, et al (2022)
Urinary metabolic signatures for differential diagnosis of diabetic and non-diabetic kidney disease. Indian Journal of Endocrinology and Metabolism 26:S11
Banerjee M, Pal R, Bhadada SK (2022)
Intercepting the deadly trinity of mucormycosis, diabetes and COVID-19 in India. Postgraduate medical journal 98:e108–e109
Ghosh S, Manna S, Basu M, et al (2019)
Urinary metabolomics: to distinguish diabetic kidney disease from non-diabetic kidney disease. SPRINGER 233 SPRING ST, NEW YORK, NY 10013 USA, pp S456–S456
Pal R, Banerjee M (2021)
Spurious undermining of the adjuvant role of vitamin D in COVID-19. Diabetes & Metabolic Syndrome 15:102230
Pal R, Banerjee M, Mukherjee S, et al (2021)
Dipeptidyl peptidase-4 inhibitor use and mortality in COVID-19 patients with diabetes mellitus: an updated systematic review and meta-analysis. Therapeutic Advances in Endocrinology and Metabolism 12:204201882199
Pal R, Banerjee M, Yadav U, Bhattacharjee S (2022)
Statin use and clinical outcomes in patients with COVID-19: An updated systematic review and meta-analysis. Postgraduate medical journal 98:354–359
Pal R, Joshi A, Bhadada SK, Banerjee M, Vaikkakara S, Mukhopadhyay S
Endocrine Follow-up During Post-Acute COVID-19: Practical Recommendations Based on Available Clinical Evidence. Endocr Pract. 2022 Apr;28(4):425-432. doi: 10.1016/j.eprac.2022.02.003
Pal R, Banerjee M, Bhadada SK.
Cortisol concentrations and mortality from COVID-19. The Lancet Diabetes & Endocrinology. 2020 Oct 1;8(10):809.
Pal R, Banerjee M, Yadav U, Bhattacharjee S.
Clinical profile and outcomes in COVID- 19 patients with diabetic ketoacidosis: A systematic review of literature. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2020 Aug 18.
Mandal S, Mukhopadhyay P, Banerjee M, Ghosh S.
Clinical, endocrine, metabolic profile, and bone health in Sheehan's syndrome. Indian Journal of Endocrinology and Metabolism. 2020 Jul 1;24(4):338.
Pal R, Banerjee M
Are people with uncontrolled diabetes mellitus at high risk of reinfections with COVID-19?
Pal R, Banerjee M
COVID-19 and the endocrine system: exploring the unexplored
Basu M, Pandit K, Banerjee M, Mondal SA, Mukhopadhyay P, Ghosh S
Profile of auto- antibodies (Disease related and other) in children with type 1 diabetes
Basu M, Banerjee M, Mukhopadhyay P, Ghosh S
Trends of seasonality and age of onset in T1DM: A snapshot from Eastern India
Pal R, Banerjee M
Comment on 'Is the type of diabetes treatment relevant to outcome of COVID‐19?'
Banerjee M, Chakraborty S, Pal R
Teleconsultation and diabetes care amid COVID-19 pandemic in India: scopes and challenges
Bhattacharjee S, Banerjee M, Pal R
COVID-19-associated Hemophagocytic Lymphohistiocytosis and Coagulopathy: Targeting the Duumvirate
Banerjee M, Chakraborty S, Pal R
Diabetes self-management amid COVID-19 pandemic
Banerjee M, Gupta S, Pal R, Ghosh S
Secondary Amenorrhea as primary presentation of Idiopathic Intracranial Hypertension
Banerjee M, Majumdar M, Kundu PK, Maisnam I, Mukherjee AK
Clinical profile of asymptomatic bacteriuria in type 2 diabetes mellitus: An Eastern India perspective
Banerjee M, Mondal SK, Maisnam I, Mukherjee AK
Jaundice and anaemia as presenting features of an incomplete autoimmune polyglandular syndrome type II
Bhattacharjee S, Banerjee M
Immune Thrombocytopenia Secondary to COVID-19: a Systematic Review
Bhattacharjee S, Banerjee M, Pal R
ABO blood groups and severe outcomes in COVID-19: A meta-analysis